a prospective multicenter cross-sectional study of Chinese appropriateness evaluation of Non-vitamin K antagonist oral anticoagulants (NOACs) prescribing in atrial fibrillation patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035908

Enrollment

Unknown

Registered

2020-08-19

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatients or outpatients with atrial fibrillation (AF) aged >= 18 years will be continuously included, including initial or ongoing anticoagulation therapy.

Exclusion criteria

Exclusion criteria: 1. Patients with atrial fibrillation due to transient factors including hyperthyroidism, acute pulmonary embolism, recent major surgery or acute myocardial infarction. 2. Patients with deep venous thromboembolism, pulmonary embolism and other anticoagulant indications after total hip / knee arthroplasty.

Design outcomes

Primary

Measure	Time frame
the prevalence of inappropriate prescription of NOACs;	—

Secondary

Measure	Time frame
CHA2DS2-VASc scores;HAS-BLED scores;	—

Countries

China

Contacts

Public ContactZheng Ding

Fuwai hospital, Chinese Academy of Medical Sciences

409883075@qq.com+86 18612452371

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026